Carcidiag Biotechnologies

France
Itancourt, Hauts-de-France, France, 23000

Company profile

Carcidiag Biotechnologies company profile

Carcidiag Biotechnologies develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells for the prevention of carcinogenesis affecting the ENT sphere (tongue, pharynx, oral mucosa), the colorectal area and the lungs as well as the gynecological cancers.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2017-01-01, Year

Headquarters

Postal code
23000
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1.1M
Last funding
Seed / $1.1M / 2017-01-01
Last equity funding
Seed / $1.1M
Founders
2

Founders and investors

Founders

Christian LauranceVincent Carre